Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media

References

• Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol. 2014;32(10):992–1000. doi:10.1038/nbt.3040. PMID:25299917.
   PubMed Web of Science ®Google Scholar
• Rohrbach P, Broders O, Toleikis L, Dubel S. Therapeutic antibodies and antibody fusion proteins. Biotechnol Genet Eng Rev. 2003;20:137–63. PubMed. doi:10.1080/02648725.2003.10648041. PMID:14997850.
   PubMed Web of Science ®Google Scholar
• Watier H, Reichert JM. Evolution of antibody therapeutics. In: Vaughn T, Osbourn J, Jallal B, editors. Protein Therapeutics. Weinheim, Germany: Wiley-VCH; 2017. p. 25–49.
   Google Scholar
• Scavone C, Sportiello L, Berrino L, Rossi F, Capuano A. Biosimilars in the European Union from comparability exercise to real world experience: what we achieved and what we still need to achieve. Pharmacol Res. 2017;119:265–71. doi:10.1016/j.phrs.2017.02.006. PMID:28214611.
   PubMed Web of Science ®Google Scholar
• von Richter O, Skerjanec A, Afonso M, Sanguino Heinrich S, Poetzl J, Woehling H, Velinova M, Koch A, Kollins D, Macke L, et al. GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes. Br J Clin Pharmacol. 2017;83(4):732–41. doi:10.1111/bcp.13170. PMID:27790726.
   PubMed Web of Science ®Google Scholar
• Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A. Cell culture processes for monoclonal antibody production. MAbs 2010;2(5):466–79. doi:10.4161/mabs.2.5.12720. PMID:20622510.
   PubMed Web of Science ®Google Scholar
• Rader RA, Langer ES. 30 years of upstream productivity improvements. BioProcess Int. 2015;13(2):10–14.
   Google Scholar
• Huang YM, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog. 2010 Sep-Oct;26(5):1400–10. doi:10.1002/btpr.436. PMID:20945494.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Kikuchi T, Wada R, Omasa T. The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside. Cytotechnology. 2017;69(3):511–21. doi:10.1007/s10616-017-0066-7. PMID:28251404.
   PubMed Web of Science ®Google Scholar
• Derfus GE, Dizon-Maspat J, Broddrick JT, Velayo AC, Toschi JD, Santuray RT, Hsu SK, Winter CM, Krishnan R, Amanullah A. Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest. MAbs. 2014;6(3):679–88. doi:10.4161/mabs.28257. PMID:24552690.
   PubMed Web of Science ®Google Scholar
• Prentice KM, Gillespie R, Lewis N, Fujimori K, McCoy R, Bach J, Connell-Crowley L, Eakin CM. Hydroxocobalamin association during cell culture results in pink therapeutic proteins. MAbs. 2013;5(6):974–81. doi:10.4161/mabs.25921. PMID:23924851.
   PubMed Web of Science ®Google Scholar
• Vijayasankaran N, Varma S, Yang Y, Mun M, Arevalo S, Gawlitzek M, Swartz T, Lim A, Li F, Zhang B, et al. Effect of cell culture medium components on color of formulated monoclonal antibody drug substance. Biotechnol Prog. 2013;29(5):1270–7. doi:10.1002/btpr.1772. PMID:23804462.
   PubMed Web of Science ®Google Scholar
• Xu J, Jin M, Song H, Huang C, Xu X, Tian J, et al. Brown drug substance color investigation in cell culture manufacturing using chemically defined media: A case study. Process Biochem. 2014;49(1):130–9. doi:10.1016/j.procbio.2013.10.015.
   Web of Science ®Google Scholar
• Chumsae C, Hossler P, Raharimampionona H, Zhou Y, McDermott S, Racicot C, Radziejewski C, Zhou ZS. When Good Intentions Go Awry: Modification of a Recombinant Monoclonal Antibody in Chemically Defined Cell Culture by Xylosone, an Oxidative Product of Ascorbic Acid. Anal Chem. 2015;87(15):7529–34. doi:10.1021/acs.analchem.5b00801. PMID:26151084.
   PubMed Web of Science ®Google Scholar
• Hossler P, Wang M, McDermott S, Racicot C, Chemfe K, Zhang Y, Chumsae C, Manuilov A. Cell culture media supplementation of bioflavonoids for the targeted reduction of acidic species charge variants on recombinant therapeutic proteins. Biotechnol Prog. 2015 Jul-Aug;31(4):1039–52. doi:10.1002/btpr.2095. PMID:25920009.
   PubMed Web of Science ®Google Scholar
• Kaschak T, Boyd D, Lu F, Derfus G, Kluck B, Nogal B, Emery C, Summers C, Zheng K, Bayer R, et al. Characterization of the basic charge variants of a human IgG1: Effect of copper concentration in cell culture media. MAbs. 2011;3(6):577–83. doi:10.4161/mabs.3.6.17959. PMID:22123059
   PubMed Web of Science ®Google Scholar
• Luo J, Vijayasankaran N, Autsen J, Santuray R, Hudson T, Amanullah A, Li F. Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process. Biotechnol Bioeng. 2012;109(1):146–56. doi:10.1002/bit.23291. PMID:21964570.
   PubMed Web of Science ®Google Scholar
• Pacis E, Yu M, Autsen J, Bayer R, Li F. Effects of cell culture conditions on antibody N-linked glycosylation–what affects high mannose 5 glycoform. Biotechnol Bioeng. 2011;108(10):2348–58. doi:10.1002/bit.23200. PMID:21557201.
   PubMed Web of Science ®Google Scholar
• Sha S, Agarabi C, Brorson K, Lee DY, Yoon S. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies. Trends Biotechnol. 2016;34(10):835–46. doi:10.1016/j.tibtech.2016.02.013. PMID:27016033.
   PubMed Web of Science ®Google Scholar
• Huang CJ, Lin H, Yang JX. A robust method for increasing Fc glycan high mannose level of recombinant antibodies. Biotechnol Bioeng. 2015;112(6):1200–9. doi:10.1002/bit.25534. PMID:25565276.
   PubMed Web of Science ®Google Scholar
• Louie S, Haley B, Marshall B, Heidersbach A, Yim M, Brozynski M, Tang D, Lam C, Petryniak B, Shaw D, et al. FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality. Biotechnol Bioeng. 2017;114(3):632–44. doi:10.1002/bit.26188. PMID:27666939.
   PubMed Web of Science ®Google Scholar
• Torkashvand F, Vaziri B. Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components. Iran Biomed J. 2017;21(3):131–41. PubMed doi:10.18869/acadpub.ibj.21.3.131. PMID:28176518.
   PubMedGoogle Scholar
• Wurm FM. CHO Quasispecies—Implications for Manufacturing Processes. Processes. 2013;1:296–311. doi:10.3390/pr1030296.
   Google Scholar
• Xu S, Hoshan L, Chen H. Improving lactate metabolism in an intensified CHO culture process: productivity and product quality considerations. Bioprocess and Biosyst Eng. 2016;39:1689–702. doi:10.1007/s00449-016-1644-3.
   PubMed Web of Science ®Google Scholar
• Borys MC, Dalal NG, Abu-Absi NR, Khattak SF, Jing Y, Xing Z, Li ZJ. Effects of culture conditions on N-glycolylneuraminic acid (Neu5Gc) content of a recombinant fusion protein produced in CHO cells. Biotechnol Bioeng. 2010 Apr 15;105(6):1048–57. PMID:20039310.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Zheng C, Chen Y, Huang Z, Wang Y, Fu Q, Zeng C, Wu T, Yang L, Qi N. Different fermentation processes produced variants of an anti-CD52 monoclonal antibody that have divergent in vitro and in vivo characteristics. Appl Microbiol Biotechnol. 2017 Aug;101(15):5997–6006. doi:10.1007/s00253-017-8312-7. PMID:28512676.
   PubMed Web of Science ®Google Scholar
• Aghamohseni H, Spearman M, Ohadi K, Braasch K, Moo-Young M, Butler M, Budman HM. A semi-empirical glycosylation model of a camelid monoclonal antibody under hypothermia cell culture conditions. J Ind Microbiol Biotechnol. 2017 Jul;44(7):1005–20. doi:10.1007/s10295-017-1926-z. PMID:28285402.
   PubMed Web of Science ®Google Scholar
• Kishishita S, Nishikawa T, Shinoda Y, Nagashima H, Okamoto H, Takuma S, Aoyagi H. Effect of temperature shift on levels of acidic charge variants in IgG monoclonal antibodies in Chinese hamster ovary cell culture. J Biosci Bioeng. 2015 Jun;119(6):700–5. doi:10.1016/j.jbiosc.2014.10.028. PMID:25466646.
   PubMed Web of Science ®Google Scholar
• Song H, Xu J, Jin M, Huang C, Bongers J, Bai H, Wu W, Ludwig R, Li Z, Tao L, et al. Investigation of Color in a Fusion Protein Using Advanced Analytical Techniques: Delineating Contributions from Oxidation Products and Process Related Impurities. Pharm Res. 2016;33:932–41. doi:10.1007/s11095-015-1839-3. PMID:26658915.
   PubMed Web of Science ®Google Scholar
• Du C, Martin R, Huang Y, Borwankar A, Tan Z, West J, Singh N, Borys M, Ghose S, Ludwig R, et al. Vitamin B12 association with mAbs: Mechanism and potential mitigation strategies. Biotechnol Bioeng. 2018; In press:1–10. doi:10.1002/bit.26511.
   Web of Science ®Google Scholar
• Bai Y, Wu C, Zhao J, Liu YH, Ding W, Ling WLW. Role of iron and sodium citrate in animal protein-free CHO cell culture medium on cell growth and monoclonal antibody production. Biotechnol Prog. 2011;27(1):209–19. doi:10.1002/btpr.513. PMID:21312368.
   PubMed Web of Science ®Google Scholar
• Du Y, Walsh A, Ehrick R, Xu W, May K, Liu H. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. MAbs. 2012;4(5):578–85. doi:10.4161/mabs.21328. PMID:22820257.
   PubMed Web of Science ®Google Scholar
• Li B, Tesar D, Boswell CA, Cahaya HS, Wong A, Zhang J, Meng YG, Eigenbrot C, Pantua H, Diao J, et al. Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge. MAbs. 2014;6(5):1255–64. doi:10.4161/mabs.29809. PMID:25517310.
   PubMed Web of Science ®Google Scholar
• Aisen P, Enns C, Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol. 2001;33(10):940–59. doi:10.1016/S1357-2725(01)00063-2. PMID:11470229.
   PubMed Web of Science ®Google Scholar
• Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: Molecular control of mammalian iron metabolism. Cell. 2004;117(3):285–97. doi:10.1016/S0092-8674(04)00343-5. PMID:15109490.
   PubMed Web of Science ®Google Scholar
• Basset P, Zwiller J. Iron-induced L1210 Cell Growth: Evidence of a Transferrin-independent Iron Transport. Cancer Res 1986;46:1644–7. PMID:3948154.
   PubMed Web of Science ®Google Scholar
• Metcalfe H, Field, R. P., Froud, S. J. The use of 2-hydroxy-2, 4, 6- cycloheptarin-1-one (tropolone) as a replacement for transferrin. In: Spier RE GJ, Berthold W, editors. Animal Cell Technology: Products of Today, Prospects of Tomorrow. Oxford, UK: Butterworth- Heinemann; 1994. p. 88–90.
   Google Scholar
• Musílková J, Kovář J. Additive stimulatory effect of extracellular calcium and potassium on non-transferrin ferric iron uptake by HeLa and K562 cells. Biochim Biophys Acta. 2001;1514(1):117–26. doi:10.1016/S0005-2736(01)00367-4. PMID:11513809.
   PubMed Web of Science ®Google Scholar
• Sturrock A, Alexander J, Lamb J, Craven CM, Kaplan J. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem. 1990;265(6):3139–45. PMID:2105943.
   PubMed Web of Science ®Google Scholar
• Inman RS, Wessling-Resnick M. Characterization of transferrin-independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake. J Biol Chem. 1993;268(12):8521–8. PMID:8473296.
   PubMed Web of Science ®Google Scholar
• Zhang J, Robinson D, Salmon P. A novel function for selenium in biological system: selenite as a highly effective iron carrier for Chinese hamster ovary cell growth and monoclonal antibody production. Biotechnol Bioeng. 2006;95(6):1188–97. doi:10.1002/bit.21081. PMID:16937407.
   PubMed Web of Science ®Google Scholar
• Neumannova V, Richardson DR, Kriegerbeckova K, Kovar J. Growth of human tumor cell lines in transferrin-free, low-iron medium. In Vitro Cell Dev Biol Anim. 1995;31(8):625–32. doi:10.1007/BF02634316. PMID:8528518.
   PubMed Web of Science ®Google Scholar
• Gawlitzek M, Estacio M, Fürch T, Kiss R. Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells. Biotech Bioeng. 2009;103(6):1164–75. doi:10.1002/bit.22348.
   PubMed Web of Science ®Google Scholar
• Beckmann TF, Kramer O, Klausing S, Heinrich C, Thute T, Buntemeyer H, Hoffrogge R, Noll T. Effects of high passage cultivation on CHO cells: a global analysis. Appl Microbiol Biotechnol. 2012 May;94(3):659–71. doi:10.1007/s00253-011-3806-1. PMID:22331235.
   PubMed Web of Science ®Google Scholar
• Hassett B, Singh, E, Mahgoub, E, O'Brien, J, Vicik, SM, Fitzpatrick, B. Manufacturing history of etanercept (Enbrel): Consistency of product quality through major process revisions. MAbs. 2018;10(1):159–65. doi:10.1080/19420862.2017.1388483.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kwon YB, Cho JM, Park KH, Chang SJ, Kim DI. Effect of process change from perfusion to fed-batch on product comparability for biosimilar monoclonal antibody. Process Biochem. 2012;47(9):1411–8. doi:10.1016/j.procbio.2012.05.017.
   Web of Science ®Google Scholar
• Hanning RM, Michell, MK, Atkinson, SA. In Vitro Solubility of Calcium Glycerophosphate Versus Conventional Mineral Salts in Pediatric Parenteral Nutrition Solutions. J Pediatr Gastroenterol and Nutr. 1989;9:67–72. doi:10.1097/00005176-198909010-00013.. PMID:2506324.
   PubMed Web of Science ®Google Scholar
• Xing Z, Kenty B, Koyrakh I, Borys M, Pan SH, Li ZJ. Optimizing amino acid composition of CHO cell culture media for a fusion protein production. Process Biochem. 2011;46(7):1423–9. doi:10.1016/j.procbio.2011.03.014.
   Web of Science ®Google Scholar